Subscriber Content Preview | Request a free trialSearch  
  Go

Entries tagged "Merck"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Merck."

11 result(s) displayed (1 - 11 of 11)


Anadys acquisition sign of more to come

Roche's $230 million deal for the hepatitis C developer shows that Big Pharma may target smaller pharmaceutical companies to compete in the market. Continue reading

Posted on October 17, 2011 3:48 PM




The marriage of theory and practice

Abigail Barrow and Steven Shapin on the interaction of science, technology and economic development. Continue reading

Posted on May 15, 2009 11:59 AM




A whole new ballgame

Recent big-ticket pharma deals illustrate the evolution of financing outs and breakup fees. Continue reading

Posted on March 24, 2009 2:55 PM




Paging Dr. Scholl

The consumer-products subplot in the pharmaceutical megamergers. Continue reading

Posted on March 20, 2009 1:59 PM




Little pharma blues

As the economy foundered, drug industry insiders looked forward to an M&A frenzy. But with a few exceptions, deals occurred only at the top of the food chain. Continue reading

Posted on March 20, 2009 1:48 PM




Merck, Schering play follow the pharma

Damian Ridealgh and other Fried Frank attorneys advised Merck on its deal for Schering. Continue reading

Posted on March 20, 2009 1:44 PM




Abbott leads the biotech wave

Skadden's Brian McCarthy led a team advising AMO in its sale to Abbott Labs. Continue reading

Posted on January 23, 2009 12:43 PM




They need a new drug

Expect Big Pharma to go shopping in biotechland, but with an eye for fire sales. Continue reading

Posted on January 9, 2009 2:10 PM




Strength in numbers

Goldman Sachs' Susan Scher. Continue reading

Posted on December 1, 2008 2:18 PM




This won't hurt a bit

An examination of U.S. healthcare under the Obama administration. Continue reading

Posted on November 14, 2008 3:15 PM




Litigation risk

FASB weighs requiring companies to estimate their exposure to legal damages; business tries to bury the idea. Continue reading

Posted on August 29, 2008 11:43 AM






Movable Type search results powered by Fast Search



Popular tags




Movers & Shakers

Launch Movers and shakers slideshow

Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.

Video

Coming back for more

Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video

Sectors